Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
A Phase 3 Study of KRX-0502 (Ferric Citrate) for the Treatment of Iron Deficiency Anemia (IDA) in Adult Subjects With Non-Dialysis Dependent (NDD) Chronic Kidney Disease
Status: Enrolling
Updated:  2/22/2018
Research Management, Inc
mi
from
Austin, TX
KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
A Phase 3 Study of KRX-0502 (Ferric Citrate) for the Treatment of Iron Deficiency Anemia (IDA) in Adult Subjects With Non-Dialysis Dependent (NDD) Chronic Kidney Disease
Status: Enrolling
Updated: 2/22/2018
Research Management, Inc
mi
from
Austin, TX
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
A Phase 3 Study of KRX-0502 (Ferric Citrate) for the Treatment of Iron Deficiency Anemia (IDA) in Adult Subjects With Non-Dialysis Dependent (NDD) Chronic Kidney Disease
Status: Enrolling
Updated:  2/22/2018
Research Management, Inc
mi
from
Austin, TX
KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
A Phase 3 Study of KRX-0502 (Ferric Citrate) for the Treatment of Iron Deficiency Anemia (IDA) in Adult Subjects With Non-Dialysis Dependent (NDD) Chronic Kidney Disease
Status: Enrolling
Updated: 2/22/2018
Research Management, Inc
mi
from
Austin, TX
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
A Phase 3 Study of KRX-0502 (Ferric Citrate) for the Treatment of Iron Deficiency Anemia (IDA) in Adult Subjects With Non-Dialysis Dependent (NDD) Chronic Kidney Disease
Status: Enrolling
Updated:  2/22/2018
TAD Clinical Research
mi
from
Lufkin, TX
KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
A Phase 3 Study of KRX-0502 (Ferric Citrate) for the Treatment of Iron Deficiency Anemia (IDA) in Adult Subjects With Non-Dialysis Dependent (NDD) Chronic Kidney Disease
Status: Enrolling
Updated: 2/22/2018
TAD Clinical Research
mi
from
Lufkin, TX
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
A Phase 3 Study of KRX-0502 (Ferric Citrate) for the Treatment of Iron Deficiency Anemia (IDA) in Adult Subjects With Non-Dialysis Dependent (NDD) Chronic Kidney Disease
Status: Enrolling
Updated:  2/22/2018
Clinical Advancement Center, PLLC
mi
from
San Antonio, TX
KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
A Phase 3 Study of KRX-0502 (Ferric Citrate) for the Treatment of Iron Deficiency Anemia (IDA) in Adult Subjects With Non-Dialysis Dependent (NDD) Chronic Kidney Disease
Status: Enrolling
Updated: 2/22/2018
Clinical Advancement Center, PLLC
mi
from
San Antonio, TX
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
A Phase 3 Study of KRX-0502 (Ferric Citrate) for the Treatment of Iron Deficiency Anemia (IDA) in Adult Subjects With Non-Dialysis Dependent (NDD) Chronic Kidney Disease
Status: Enrolling
Updated:  2/22/2018
Kidney & Hypertension Specialists
mi
from
San Antonio, TX
KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
A Phase 3 Study of KRX-0502 (Ferric Citrate) for the Treatment of Iron Deficiency Anemia (IDA) in Adult Subjects With Non-Dialysis Dependent (NDD) Chronic Kidney Disease
Status: Enrolling
Updated: 2/22/2018
Kidney & Hypertension Specialists
mi
from
San Antonio, TX
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
A Phase 3 Study of KRX-0502 (Ferric Citrate) for the Treatment of Iron Deficiency Anemia (IDA) in Adult Subjects With Non-Dialysis Dependent (NDD) Chronic Kidney Disease
Status: Enrolling
Updated:  2/22/2018
San Antonio Kidney Disease Center
mi
from
San Antonio, TX
KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
A Phase 3 Study of KRX-0502 (Ferric Citrate) for the Treatment of Iron Deficiency Anemia (IDA) in Adult Subjects With Non-Dialysis Dependent (NDD) Chronic Kidney Disease
Status: Enrolling
Updated: 2/22/2018
San Antonio Kidney Disease Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
A Phase 3 Study of KRX-0502 (Ferric Citrate) for the Treatment of Iron Deficiency Anemia (IDA) in Adult Subjects With Non-Dialysis Dependent (NDD) Chronic Kidney Disease
Status: Enrolling
Updated:  2/22/2018
Mendez Center for CLinical Research, LLC
mi
from
Alexandria, VA
KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
A Phase 3 Study of KRX-0502 (Ferric Citrate) for the Treatment of Iron Deficiency Anemia (IDA) in Adult Subjects With Non-Dialysis Dependent (NDD) Chronic Kidney Disease
Status: Enrolling
Updated: 2/22/2018
Mendez Center for CLinical Research, LLC
mi
from
Alexandria, VA
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
A Phase 3 Study of KRX-0502 (Ferric Citrate) for the Treatment of Iron Deficiency Anemia (IDA) in Adult Subjects With Non-Dialysis Dependent (NDD) Chronic Kidney Disease
Status: Enrolling
Updated:  2/22/2018
Nephrology Associates of Northern VA, Inc.
mi
from
Fairfax, VA
KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
A Phase 3 Study of KRX-0502 (Ferric Citrate) for the Treatment of Iron Deficiency Anemia (IDA) in Adult Subjects With Non-Dialysis Dependent (NDD) Chronic Kidney Disease
Status: Enrolling
Updated: 2/22/2018
Nephrology Associates of Northern VA, Inc.
mi
from
Fairfax, VA
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
A Phase 3 Study of KRX-0502 (Ferric Citrate) for the Treatment of Iron Deficiency Anemia (IDA) in Adult Subjects With Non-Dialysis Dependent (NDD) Chronic Kidney Disease
Status: Enrolling
Updated:  2/22/2018
Peninsula Kidney Associates
mi
from
Hampton, VA
KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
A Phase 3 Study of KRX-0502 (Ferric Citrate) for the Treatment of Iron Deficiency Anemia (IDA) in Adult Subjects With Non-Dialysis Dependent (NDD) Chronic Kidney Disease
Status: Enrolling
Updated: 2/22/2018
Peninsula Kidney Associates
mi
from
Hampton, VA
Click here to add this to my saved trials
KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
A Phase 3 Study of KRX-0502 (Ferric Citrate) for the Treatment of Iron Deficiency Anemia (IDA) in Adult Subjects With Non-Dialysis Dependent (NDD) Chronic Kidney Disease
Status: Enrolling
Updated:  2/22/2018
Capital Nephrology Medical Group
mi
from
Sacramento, CA
KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD
A Phase 3 Study of KRX-0502 (Ferric Citrate) for the Treatment of Iron Deficiency Anemia (IDA) in Adult Subjects With Non-Dialysis Dependent (NDD) Chronic Kidney Disease
Status: Enrolling
Updated: 2/22/2018
Capital Nephrology Medical Group
mi
from
Sacramento, CA
Click here to add this to my saved trials
Pharmacogenetics to Predict Drug Interactions in Kidney Transplant Recipients
Utilizing Pharmacogenetics to Predict Drug Interactions in Kidney Transplant Recipients
Status: Enrolling
Updated:  2/22/2018
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Pharmacogenetics to Predict Drug Interactions in Kidney Transplant Recipients
Utilizing Pharmacogenetics to Predict Drug Interactions in Kidney Transplant Recipients
Status: Enrolling
Updated: 2/22/2018
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Effect of Sulodexide in Early Diabetic Nephropathy
The Collaborative Study Group Trial: The Effect of Sulodexide in Patients With Type 2 Diabetes and Microalbuminuria
Status: Enrolling
Updated:  2/22/2018
The Collaborative Study Group, Clinical Coordinating Center for U.S. and Canadian Clinics, Rush University Medical Center
mi
from
Chicago, IL
Effect of Sulodexide in Early Diabetic Nephropathy
The Collaborative Study Group Trial: The Effect of Sulodexide in Patients With Type 2 Diabetes and Microalbuminuria
Status: Enrolling
Updated: 2/22/2018
The Collaborative Study Group, Clinical Coordinating Center for U.S. and Canadian Clinics, Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Effect of Sulodexide in Early Diabetic Nephropathy
The Collaborative Study Group Trial: The Effect of Sulodexide in Patients With Type 2 Diabetes and Microalbuminuria
Status: Enrolling
Updated:  2/22/2018
The Collaborative Study Group, Clinical Coordinating Center for the Pacific Region, Monash Medical Center
mi
from
Melbourne,
Effect of Sulodexide in Early Diabetic Nephropathy
The Collaborative Study Group Trial: The Effect of Sulodexide in Patients With Type 2 Diabetes and Microalbuminuria
Status: Enrolling
Updated: 2/22/2018
The Collaborative Study Group, Clinical Coordinating Center for the Pacific Region, Monash Medical Center
mi
from
Melbourne,
Click here to add this to my saved trials
Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans
Efficacy of Sirolimus-Based, Steroid Avoidance Maintenance Immunosuppression in Black de Novo Kidney Transplant Recipients
Status: Enrolling
Updated:  2/27/2018
University of Michigan Health Center
mi
from
Ann Arbor, MI
Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans
Efficacy of Sirolimus-Based, Steroid Avoidance Maintenance Immunosuppression in Black de Novo Kidney Transplant Recipients
Status: Enrolling
Updated: 2/27/2018
University of Michigan Health Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Anesthetic Technique for AV Fistulae Creation
Status: Enrolling
Updated:  3/1/2018
Montefiore Medical Center
mi
from
Bronx, NY
Anesthetic Technique for AV Fistulae Creation
Status: Enrolling
Updated: 3/1/2018
Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
The Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency
A Phase 1, Open-label, Single-dose Study to Determine the Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency
Status: Enrolling
Updated:  3/1/2018
DaVita Clinical Research
mi
from
Lakewood, CO
The Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency
A Phase 1, Open-label, Single-dose Study to Determine the Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency
Status: Enrolling
Updated: 3/1/2018
DaVita Clinical Research
mi
from
Lakewood, CO
Click here to add this to my saved trials
The Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency
A Phase 1, Open-label, Single-dose Study to Determine the Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency
Status: Enrolling
Updated:  3/1/2018
DaVita Clinical Research
mi
from
Minneapolis, MN
The Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency
A Phase 1, Open-label, Single-dose Study to Determine the Safety and Pharmacokinetics of Carbavance™ (RPX2014/RPX7009) in Subjects With Renal Insufficiency
Status: Enrolling
Updated: 3/1/2018
DaVita Clinical Research
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes
Randomized Study of Antihypertensives and Antilipemics in American Indians With Non-Insulin-Dependent Diabetes Mellitus at High Risk of Developing Nephropathy and Cardiovascular Disease
Status: Enrolling
Updated:  3/5/2018
Hennepin County Medical Center
mi
from
Minneapolis, MN
Drugs for High Blood Pressure and High Cholesterol in American Indians With Type 2 Diabetes
Randomized Study of Antihypertensives and Antilipemics in American Indians With Non-Insulin-Dependent Diabetes Mellitus at High Risk of Developing Nephropathy and Cardiovascular Disease
Status: Enrolling
Updated: 3/5/2018
Hennepin County Medical Center
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Southwestern American Indian Center
mi
from
Phoenix, AZ
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Southwestern American Indian Center
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Southern California
mi
from
Los Angeles, CA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Colorado Health Sciences Ctr.
mi
from
Aurora, CO
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Colorado Health Sciences Ctr.
mi
from
Aurora, CO
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Louisiana State University
mi
from
Baton Rouge, LA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Louisiana State University
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Johns Hopkins Pro-Health
mi
from
Baltimore, MD
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Johns Hopkins Pro-Health
mi
from
Baltimore, MD
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Diabetes Center
mi
from
Boston, MA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Joslin Diabetes Center
mi
from
Boston, MA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Northern Navajo Medical Center
mi
from
Shiprock, NM
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Northern Navajo Medical Center
mi
from
Shiprock, NM
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Columbia University
mi
from
New York, NY
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Columbia University
mi
from
New York, NY
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
The University of Pennsylvania Medical Center
mi
from
Philadelphia, PA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
The University of Pennsylvania Medical Center
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Pittsburgh
mi
from
Pittsburgh, PA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Pittsburgh
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Miriam Hospital
mi
from
Providence, RI
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Miriam Hospital
mi
from
Providence, RI
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Tennessee, Memphis
mi
from
Memphis, TN
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Tennessee, Memphis
mi
from
Memphis, TN
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Baylor College of Medicine
mi
from
Houston, TX
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
University of Texas Health Sciences Center
mi
from
San Antonio, TX
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
University of Texas Health Sciences Center
mi
from
San Antonio, TX
Click here to add this to my saved trials
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated:  3/6/2018
Univ of Washington
mi
from
Seattle, WA
Look AHEAD: Action for Health in Diabetes
Look AHEAD: Action for Health in Diabetes
Status: Enrolling
Updated: 3/6/2018
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Barbara Davis Center / University of Colorado Denver
mi
from
Aurora, CO
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Barbara Davis Center / University of Colorado Denver
mi
from
Aurora, CO
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Kaiser Permanente Colorado Institute for Health Research
mi
from
Denver, CO
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Kaiser Permanente Colorado Institute for Health Research
mi
from
Denver, CO
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Emory University and Grady Memorial Hospital
mi
from
Atlanta, GA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Emory University and Grady Memorial Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Atlanta Diabetes Associates
mi
from
Atlanta, GA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Atlanta Diabetes Associates
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Northwestern University Feinberg School of Medicine
mi
from
Chicago, IL
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Massachusetts General Hospital
mi
from
Boston, MA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Joslin Diabetes Center
mi
from
Boston, MA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
University of Massachusetts Memorial Health Care
mi
from
Worcester, MA
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
University of Massachusetts Memorial Health Care
mi
from
Worcester, MA
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Brehm Center for Diabetes Research / University of Michigan
mi
from
Ann Arbor, MI
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Brehm Center for Diabetes Research / University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Univ of Minnesota
mi
from
Minneapolis, MN
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Univ of Minnesota
mi
from
Minneapolis, MN
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Albert Einstein College of Medicine/ Montefiore Medical Center
mi
from
Bronx, NY
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Albert Einstein College of Medicine/ Montefiore Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Jacobi Medical Center
mi
from
Bronx, NY
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Jacobi Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Winthrop University Hospital
mi
from
Mineola, NY
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated:  3/7/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
A Multicenter Clinical Trial of Allopurinol to Prevent Kidney Function Loss in Type 1 Diabetes
PERL: A Multicenter Clinical Trial of Allopurinol to Prevent GFR Loss in T1D
Status: Enrolling
Updated: 3/7/2018
Icahn School of Medicine at Mount Sinai
mi
from
New York, NY
Click here to add this to my saved trials